Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rapid dose escalation of quetiapine versus conventional escalation in the treatment of patients with acute schizophrenia - multicentre, double-blind, parallel group, randomized study.

Trial Profile

Rapid dose escalation of quetiapine versus conventional escalation in the treatment of patients with acute schizophrenia - multicentre, double-blind, parallel group, randomized study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Acronyms RACE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 01 Apr 2009 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top